SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate)
Overview
SYN-AKE is a synthetic dipeptide derivative inspired by the venom peptide waglerin-1 from the Temple viper. It acts as a competitive antagonist at nicotinic acetylcholine receptors on the postsynaptic muscle membrane, thereby reducing muscle contraction and potentially smoothing expression lines. The compound is marketed as a topical alternative to botulinum toxin, though with substantially lower receptor affinity and clinical effect.
Key Research Findings
In vitro receptor binding assays have confirmed weak antagonism at muscle-type nicotinic receptors. Small-scale cosmetic trials have suggested modest reductions in forehead and crow's feet wrinkle depth after four weeks of topical application, though blinding and placebo controls are often not rigorously detailed. No studies in peer-reviewed dermatology or pharmacology journals have established standardized clinical efficacy.
Topical
Investigational
Interested in SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate)?
Find a verified provider experienced with SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate) protocols in your area. All providers are credentialed and use compliant sourcing.
Find a SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate) ProviderRelated Peptides
Afamelanotide (Scenesse)
FDA ApprovedA synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine at position 4 that confers enhanced potency and enzymatic stability. Afamelanotide activates melanocortin-1 receptors (MC1R) on melanocytes, stimulating eumelanin production independent of UV exposure. The resulting increase in skin eumelanin provides photoprotection by absorbing UV radiation and scavenging reactive oxygen species.
Argireline (Acetyl Hexapeptide-8)
InvestigationalArgireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter release at the neuromuscular junction. It functions as a competitive inhibitor of the SNARE complex, reducing catecholamine release and potentially diminishing muscle contraction intensity in facial expression muscles. This mechanism provides a topical alternative rationale to botulinum toxin for addressing expression lines, though with markedly lower potency.
Matrixyl (Palmitoyl Pentapeptide-4)
InvestigationalMatrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety to enhance dermal penetration. It is proposed to stimulate fibroblast activity and upregulate synthesis of extracellular matrix components including collagen types I and III, fibronectin, and hyaluronic acid. The peptide serves as a matrikine fragment mimetic, signaling tissue remodeling pathways in aged or photodamaged skin.
Matrixyl 3000
InvestigationalMatrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR). The formulation is designed to synergistically promote collagen and fibronectin synthesis while reducing interleukin-6 mediated inflammation in dermal fibroblasts. Both peptides carry palmitic acid for enhanced lipid solubility and stratum corneum permeation.